A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L) by Bahmani, M. et al.
Topical Review Article
A Review on Ethnobotanical
and Therapeutic Uses of Fenugreek
(Trigonella foenum-graceum L)
Mahmoud Bahmani, PhD1, Hedayatollah Shirzad, PhD2,
Mahmoud Mirhosseini, MD, Endocrinologist2,
Azadeh Mesripour, PhD2, and Mahmoud Rafieian-Kopaei, PhD2
Abstract
Fenugreek with the scientific name of Trigonella foenum-graceum L and with leaves consisting of 3 small obovate to oblong leaflets is an
annual herbaceous plant of the Fabaceae family. It is native to the eastern Mediterranean but is cultivated worldwide. This plant has
medicinal alkaloids, steroid compounds, and sapogenins and many uses have beenmentioned for this plant in traditional medicine. This
plant has been used to ease childbirth, to aid digestion, and as a general tonic to improve metabolism. Trigonelline is considered as the
most important metabolite of fenugreek, which is very effective in treating diabetes and decreasing blood cholesterol. Diaszhenin is
another important compound in seeds of this plant, which is used in producing medicinal steroids like contraceptive pills. Many studies
have beenperformedon the therapeutic effects and identificationof chemical compoundsof this plant. In this article, themost important
biological effects and reported compounds about fenugreek seed are reviewed and its therapeutic applications are investigated.
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Recently, there is an increasing tendency toward traditional
medicine due to occurrence of harmful effects of chemical
drugs on human health and various deficits of the modern med-
icine in treating some diseases.1
Medicinal plants have a long history of usage2 with low side
effects.3,4 Recent studies have shown promising results for
these plants in prevention5,6 and treatment7,8 of a wide variety
of diseases such as diabetes,9,10 hypertension,11,12 atherosclero-
sis,13,14 cardiovascular disease,15,16 and cancer.17,18 Medicinal
plants have also the capacities to diminish drug-induced
adverse effects19,20 and even heavy metals or other toxicities
toxicities.21,22 Therefore, they might be considered as reliable
sources for development of new drugs.
One of the medicinal plants that has been used since antiquity in
the traditional medicine of Iran and for which significant thera-
peutic properties have been mentioned is fenugreek. The seed
and aerial parts of the plant have been used, for centuries, as a
valuable source of protein in man and animal’s nutrition, and also
in the traditional medicine for various conditions. The interesting
point about fenugreek is the broad range of its therapeutic effects,
including pain relief, antidiabetes, antiatherosclerosis, anti-
inflammation, carminative, laxative, antispasmodic, anticancer,
sexual desire increasing, astringent, heart tonic, laxative, hyperten-
sion decreasing, triglyceride lowering, breast milk increasing, and
oxytocic properties are reported for this plant.23 Images of leaves
and seeds of fenugreek are given in Figures 1 and 2, respectively.
This plant has medicinal alkaloids, steroid compounds, and
sapogenins and many uses have been mentioned for this plant
in traditional medicine.23 This plant has been used to ease
childbirth, to aid digestion, and as a general tonic to improve
metabolism. Trigonelline is considered as the most important
metabolite of fenugreek, which is effective in treating diabetes
and decreasing blood cholesterol. Trigonelline as a plant hor-
mone is also used for cancer (liver cancer and cervical cancer)
and migraine. Studying the effect of trigonelline on mice shows
that this substance acts as sedative. This metabolite results from
niacin that is one of the food and medicinal supplement vita-
mins and is generally used to reduce blood lipid and sugar.24
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Diaszhenin is another important compound in seed of this
plant that is used in producing medicinal steroids like con-
traceptive pills. Many studies have been performed on thera-
peutic effects and identification of chemical compounds of
this plant. In this article, the most important biological effects
and reported compounds about fenugreek seed are reviewed
and its therapeutic applications are investigated.23
Name, Classification, and Plant
Characteristics
Trigonella foenum-graecum is an angiosperm plant that
belongs to Rosaceae order, Legouminosae family, subfamily
of Papilonaceae and Trigonela L. genus of the Trifolia group.25
The name of this plant comes from the Greek word trigonou
meaning triangle, because of the triangular shape of its leaflets.
The term foenum-graecum means ‘‘Greek hay’’ or Greek grass
because of its extensive use in ancient Greece. Fenugreek is an
herbaceous and annual plant and its height reaches to 50 cm.
This plant has a single stem that is frequently crooked, glab-
rous, or with distributed tomentums. Leaves are oval, serrated,
consisting of 3 small obovate to oblong leaflets and leaflets dis-
tributed from one point. Flowers are pale yellow or whitey pur-
ple 0.8 to 1.8 cm in diameter and pollination is done by insects.
Fruits are curved pods 3- to 11-cm long and containing 5 to 20
angled seeds 4- to 6-mm long. Seeds have bitter and aromatic
taste and their color varies from fawn yellow to brown. Its
names and scientific classifications are as follows.
Taxonomy
Kingdom: Plant25
Family: Fabaceae
Genus: Trigonella
Species: foenum-graecum
General name: Fenugreek
English name: Fenugreek
Arabic name: Hhulbah, Hhelbah
French name: Trigonelle, Senegrain, Foingrec
German name: Gemeiner, Hornklee, Bockshornklee
Indian name: Sagmethi, Methi, Kasurimethi
Italian name: Fienogreco, Erbamedica
Persian name: Shanbelileh
Origin and Distribution
This plant is indigenous to the eastern coasts of the Mediterra-
nean and North Africa. According to some experts and scho-
lars, this plant primarily was indigenous to Iran and then was
transferred to other areas. Fenugreek is widely grown in India,
China, Africa, Algeria, Saudi Arabia, Pakistan, Egypt, Turkey,
Ukraine, Spain, and Italy. This plant is frequently exported
from India, China, Turkey, and Morocco.23
More than a hundred of wild and cultivated species of Fenu-
greek have been identified in the world. According to Iranica Flora,
distribution of more than 32 species of this plant has been reported
Table 1. Distribution of Some Species of Trigonella Genus.
Species Geographical Origin
T coerulecscens Iran
T striata Iran
T moresshina Iran, India, Africa, Egypt
T foenum-graecum Iran, Turkey
T coerulescens Iran
T aphanoneora Iran
T tehranica Iran
T elliptica Iran
T monantha Iran
T astroites Iran
T uncata Iran
T anguina Iran, Sudi Arabia
T stellate Iran, Sudi Arabia
T fischeriana Turkey
T velutina Turkey
T cretica Turkey
T hamosa Sudi Arabia
T corniculata IndiaFigure 1. Trigonelline leaves.
Figure 2. Trigonelline seeds.
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in many areas of Iran, including Azerbaijan, Isfahan, Fars, Khora-
san, Semnan, Damghan, and also central regions (Table 1).25
Plant Chemistry
The main ingredients of the seed contain steroidal saponins,
alkaloids, mucilage, and fibers (50%).23
Steroidal Saponins. The most important steroidal saponins (0.1%
to 2.2%) are diosgenin (Figure 3) and yamogenin. Other sapo-
genins include tigogenin, gitogenin, sarsapogenin, yuccagenin,
and smilagenin. The seeds also contain a sapogenin peptide
ester named fenugreekine.26
Alkaloids. Trigonelline is the alkaloid of this plant that up to 36%
concentration of it has been extracted. Other alkaloids of the
seed include gentanin and carpaine choline.23
Oils. Fenugreek seeds contain fixed oil containing golden yel-
low and odorless unsaturated fatty acids (6% to 10%). Oil is
easily dissolved in ether, benzene, sulfur, and petroleum ether.
Fenugreek oil has antimicrobial activity.23
Mucilage. Mucilage compounds exist in endosperm of the seed
that produce mannose and galactose following hydrolysis.
Fenugreek is neutral and contains galactomannan and a xylene.
Fenugreek seeds have laxative property and this effect is
because of mucilage presence. Mucilage of fenugreek has
water-holding capacity against sodium alginate. Also its emul-
sifying and suspending effect is satisfactory.26
Protein Compounds. The amount of protein in this plant is high
(22% to 25%), and its protein is rich in lysine, arginine, trypto-
phan, and to some extent, histidine. It contains low levels of
sulfur-containing amino acids, threonine, valin, methionine
and high levels of lysine, arginine, and gelicin.27
Carbohydrates. The amount of carbohydrates of this plant is
about 8%. The seeds of fenugreek also contain proteinase-
inhibiting compounds. They are also reported to contain min-
erals such as iron, phosphate, calcium, and vitamins such as
nicotinic acid, B1, C, A, and D.
23
Flavonoids. The main flavonoids identified in this plant
include glycoside, orientin, isoorientin, vitexin, epigenin,
and quercetin.27
Aromatic Ingredients of Seeds. The aromatic ingredients of seeds,
including n-alkenes, sesquiterpenes, and some oxygenized
compounds like hexanol have been reported in this plant.23
Coumarins. Coumarins available in this plant are lactone ortho-
dihydroxy cinnamic acid and the presence of a coumarin
named scopoletin in fenugreek has also been reported. Other
substances like tannins and carotenoid compounds have been
reported in seeds.28
Traditional Uses of Fenugreek in Iran
According to opinion of traditional medicine experts, fenu-
greek has a dry and warm nature and its leaves have been used
to alleviate cold cough, splenomegaly, hepatitis, backache, and
bladder cooling reflex. Also, seeds of the plant have been used
as local emollient, a poultice for local inflammation, and as a
demulcent to alleviate pain of joints (arthralgia). Infusion of
this plant mixed with honey is recommended to treat asthma
and internal edemas.24 Zakariya al-Razi has used fenugreek
to treat diabetes and Sheikh Bu Ali Sina has presented some
information about therapeutic properties and benefits of this
plant in eliminating mouth odor, undesired odor of body and
sweat in his book named Medicine Law. He has also mentioned
some other properties and therapeutic benefits for this plant.29
The nature of this plant is dry and warm and has laxative
properties. Its oil is useful for hair. Mucilage of fenugreek
seeds, especially if mixed with oil of flower, treats striae cre-
ated by cold. This plant is used to treat skin diseases like black
spots and annoying odor of body, mouth, and sweat. It can treat
dandruff if it is used as a shampoo. Boiled form of fenugreek
helps treat the red spot of eye and helps soften throat and chest
and provides relief from cough. Using this plant in the form of
powder, infusion, decoction, and pomade has been very com-
mon in traditional medicine of Iran from ancient times.29 The
plant can be used for vaginal washing.1,3 This plant is locally
used as an emollient in treatment of pellagra, loss of appetite,
Figure 3. Molecular structure of trigonelline (right) and diosgenin (left).
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gastrointestinal disorders, and it is also used as a general
tonic.30
Traditional Uses of Fenugreek in Other
Countries
According to writings obtained from ancient civilizations,
fenugreek is one of the oldest medicinal plants used in Roam
and Egypt to ease childbirth and to increase milk flow. Even
today, Egyptian women use this plant as Hilba tea to alleviate
menstrual pains and sedating tummy problems.31
In the traditional medicine of China also this plant has been
used to boost physique, to treat weakness of body, and gout.
People with very slender physique in East used this plant to
have strong and well-developed physique. This plant has been
used in traditional medicine of India as a tonic and also as
breast milk stimulant and as a spice. In nonmedicinal applica-
tions this plant has been burned and fumed with incense by
Egyptians in religious rites and also used to mummify bodies.32
Recent Therapeutic and Pharmacologic
Investigations
Regarding extensive use recorded for fenugreek and its signif-
icant therapeutic value, today many studies have been con-
ducted on different effects of this plant to verify the use of
effective compounds and their mechanisms in the treatment
of diseases. Recent studies have shown that this plant has
extensive effect in treatment of different diseases. The most
important pharmacologic effects are presented below.
In Vitro Studies
The inhibitive effects of hydroalcoholic extract of fenugreek
extract on growth of cancer cells have been studied and it has
been suggested that the extract inhibits growth of these cells up
to 70%. Also intraperitoneal administration of 200 mg/kg
dosage of the mentioned extract produced 62.3% + 12.9%
inhibition of inflammation. Furthermore, in this study, 100 and
200 mg/kg doses have significantly increased number of
macrophages of the peritoneal environment (P < .01).33
The saponin-rich dry ethanolic extract of fenugreek seed
(extract:plant ratio) is 1:9. This extract with 1.25 minimum
inhibitory concentration (MIC) prevents growth of Candida
sp. fungi and Escherichia coli, Pseudomonas, Staphylococcus
aureus, and Enterococcus faecalis bacteria.34 One dry extract
prepared from seeds of fenugreek with 100 mg/kg concentra-
tion has shown mild antibacterial effect on Bordetella bronch-
iseptica, Bacillus cereus, Bacillus pumilis, Micrococcus flavus,
Sarcina lutea, E coli, and Proteus vulgare with 17- to 22-mm
inhibitory zone compared with 1 mg/mL streptomycin that cre-
ates 19- to 32-mm inhibitory zone.35 Furostanol saponins from
fenugreek do have not antibacterial effect but when trans-
formed into spirostanol-type, the produced substance exhibited
strong dose-dependent fungicidal effect against T harzianum,
Trichodermaviride, Rosellinia necatrix (MIC50 ¼ 50 mg/mL)
and Candida albicans (MIC50 ¼ 25mg/mL).19 An aqueous
fluid extract of fenugreek (1:1 ratio) shows a mild relaxant
effect on smooth muscles of isolated rabbit duodenum when
applied at 0.5 mg/mL concentration.36
Animal Studies
Clinical and animal studies have suggested that use of seed of
fenugreek reduces chronic and also acute blood sugar. In an
animal study designed to compare dry extract of fenugreek
with insulin in rat, it was shown that 15 mg/kg dose of dry
extract of fenugreek decreased 1.5 unit/kg of blood sugar, the
same as insulin, in rats made diabetic by aloxan. Cellular vari-
ables were studied and it was shown that fenugreek extract, by
activating production of insulin in adibocytes and liver cells,
was responsible this decrease in blood sugar and glucose toler-
ance.37 When fenugreek was added to hypercholesterolemia-
inducing diet for rats at levels of 15%, 30%, and 60%, the fecal
exertion of bile acids and cholesterol increased dose depen-
dently and increase of serum cholesterol was strongly inhabited
at each of the 3 dosages (P < .001).38 Addition of fenugreek at
30% to diet of rats fed on a hypercholestrolaemic diet for 4
weeks caused significant decrease in cholesterol to 201 mg/
dL compared with 423 mg/dL in positive control rats (P <
.001). Serum triglyceride levels were not affected by diet con-
taining fenugreek.39 In another study, in which dry ethanolic
extract defatted from Fenugreek was added to the hypercholes-
trolaemic diet of rats at 30 g/kg, plasma cholesterol was signif-
icantly decreased (P < .05) and this effect was attributed to
saponins in fenugreek.40 Steroid saponins purified from fenu-
greek (12.5 mg/d, per 300 g body weight of animals for 2-4
weeks) significantly lowered plasma cholesterol level in
healthy rats (P < .001) and streptozotocin-diabetic rats, but did
not have any effect on triglyceride levels.41 When a soluble gel
of fenugreek (mainly containing galactomannan) was orally
administered to rats, starch digestion and bile salt uptake were
inhibited after 600 and 80 mg loading dose of this gel by 50%.
Fenugreek administered to rats (50-200 g/kg) increased signif-
icantly the secretion of bile acids (P < .05), which possibly has
been caused by its effect to increase conversion of cholesterol
to bile salts.42 Addition of 2 or 8 g/kg of powdered fenugreek to
food of healthy and alloxan-diabetic rats for 2 weeks signifi-
cantly and dose dependently decreased total serum cholesterol
level, triglycerides, low- and very low–density lipoprotein, and
cholesterol (P < .05 and P < .001). It also increased high-
density lipoprotein cholesterol (P < .05) in inalloxan-diabetic
rats.43 When powdered fenugreek as 20%, 30%, and 60% of
diet and 3 fractions prepared from fenugreek (defatted,
saponin-free, and crude saponin added at levels equivalent to
powder of fenugreek at 30% of diet) were given for 2 weeks
to rabbits that had received high-fat diet for 9 weeks, plasma
fat profile improved. Fenugreek powder and each fraction
lowered cholesterol and triglyceride levels (P < .01) and none
of mentioned diet had effect on high-density lipoprotein cho-
lesterol but decreased ratio of plasma total cholesterol to
high-density lipoprotein cholesterol (P < .01). Fraction of crude
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saponin was more effective than fenugreek powder and other
fractions.44 In the glucose tolerance test, a suspension of fenu-
greek powder (0.25 g in 5 mL of water) was administered orally
to streptozotocin-induced diabetic rats and decreased blood
sugar level after a meal and defatted Fenugreek that was admi-
nistered orally at 1.89 g/kg body weight for 8 days decreased
blood sugar in alloxan-induced diabetic dogs (P < .05). This
dose of the product decreased response to oral glucose (P <
.05) and also decreased the basal glucagon (P < .02) in healthy
dogs.45 A fiber-rich fraction of fenugreek extract (79.4% fiber)
reduced blood sugar (P < .01) and blood cholesterol in alloxan-
induced diabetic dogs. Trigonelline purified from fenugreek at
dose of 50 g/kg body weight administered orally decreased
blood sugar significantly in alloxan-induced diabetic rats and
this effect was constant for 24 hours.46
Aqueous decoction prepared from fenugreek could decrease
blood sugar dose-dependently in healthy rats or alloxan-
induced diabetic rats that increased to its maximum effect
during 6 hours (P < .05). Blood sugar decreasing effect of dry
ethanolic extract of fenugreek (1:21 ratio) in oral administra-
tion at 200 mg/kg body weight in alloxan-induced diabetic rats
had effect similar as that of tolbutamide at the dose of 200
mg/kg.47 Decoction prepared from fenugreek (40 g in 300
mL water) significantly decreased fasting blood sugar
(17.7%) in glucose tolerance test when it was orally adminis-
tered at dose of 4 mL/kg body weight of rabbits.48 Addition
of 20% fenugreek to diet of rats for 2 weeks reduced blood glu-
cose 95% in the starch toleration test (1 g/kg body weight)
without any observed change in the glucose tolerance test.48
Addition of fenugreek powder at 2 or 8 g/kg body weight to diet
for 2 weeks decreased blood glucose in healthy rats (P < .05)
and alloxan-induced diabetic rats (P < .01) compared with the
control group. Oral administration of 10 mg dose of dry hydro-
alcoholic extract of fenugreek (containing 12.5% steroid sapo-
nin and 4.8% free amino acids) in 300 g rats for 14 days
significantly increased level of plasma insulin (P < .01) com-
pared with the control group.49
Oral chronic administration of dry hydroalcoholic extract of
fenugreek seed (12.5% saponin and 4.8% free amino acid) at
dose of 10 mg to rats for 2 weeks caused 20% increase in food
consumption (P < .01) and focus on eating (P < .01 on day 14)
without any change in amount of drinking water. The same
administered diet has decreased total cholesterol (P < .05) and
low- and very low–density lipoprotein cholesterol (P < .05) and
increased plasma insulin (P < .01).38 Oral administration of
aqueous extract (1:1) at 1 mL/100 g body weight for 5 days
accelerated improvement of digestive wounds created by phe-
nylbutazone and azepein in rats, compared with the control
group (P < .05). This effect was related to surface structure
of tissue by fenugreek extract and its mild cholinergic effect.20
Daily administration of fenugreek seed at 500 mg/kg dose for 4
weeks significantly decreased (P < .01) amount of oxalate renal
stones formation in rats. Renal stone was formed in these rats
by adding 3% glycolic acid to their diet.50
4-Hydroxyisoleucine is an important amino acid that is
present in the seeds of fenugreek. In one animal study
conducted on diabetic rats resistant to insulin and
streptozotocin-induced diabetic rats, insulin-resistant diabetic
rats and streptozotocin-induced diabetic rats fed with fructose,
the indicator of liver damage (aspartate transaminase) was
increased significantly (84% and 93%, respectively; P <
.001) compared with control group, which after 8 weeks of
treatment with 4-hydroxyisoleucine (50 mg/kg) became normal
in both groups (P < .01). In diabetic rats fed with fructose,
4-hydroxyisoleucine caused 36% decrease in blood glucose.
Treatment with 4-hydroxyisoleucine in streptozotocin-induced
diabetic rats did not change level of blood glucose and liver vari-
ables but high-density lipoprotein cholesterol was decreased by
31% (P < .05). Researchers of this study concluded that 4-
hydroxyisoleucine could control variables related to liver dam-
age in streptozotocin-induced and resistant to insulin diabetes
and lead to blood glucose decrease in the first group and high-
density lipoprotein cholesterol increased.40 In a study conducted
on rats, addition of extract of fenugreek seed to diet administered
with glucose and performing biopsy from muscle tissue after the
sport test showed that fenugreek extract increased biosynthesis
of muscle tissue glycogen by 63% compared with the control
group. In this study, which was performed on streptozotocin-
induced diabetic rats, 0.5 and 0.1 g/kg body weight of fenugreek
leaf was added daily to feed of rats and 600 mg/kg of antidiabetic
drug, glibenclamide was given to the control group. After 45
days, blood sugar concentration, glycated hemoglobin, plasma
insulin, and liver enzymes (hexokinase and glucose 6-phospha-
tase) were measured. Administration of fenugreek leaf (1 g/kg
body weight) resulted in decrease of blood sugar concentration
and also increase of plasma insulin and activity of hexokinase
enzyme (key enzyme in increase of glucose metabolism).51-53
Clinical Studies
Effectiveness in Decreasing or Controlling Blood Glucose. In a dou-
ble blind clinical study performed by Gupta et al,54 effective-
ness in controlling blood glucose was observed. Twenty-five
patients with type 2 diabetes were divided into 2 groups and
1 group consumed daily 1 g of dry hydroalcoholic extract of
fenugreek seeds and the second group consumed diet followed
by exercise to control blood sugar. After 2 months, blood sugar
was decreased in both groups (from 148.3 to 119.9 mg/dL in
the fenugreek group and from 137.5 to 113 mg/dl in the diet
group and sport) but no significant difference was observed
between the 2 groups. Researchers concluded that fenugreek
as well as diet and exercise both could be effective in con-
trolling and decreasing blood sugar of patients with type 2
diabetes. Sharma et al55 conducted a randomized, controlled,
crossover study in patients with type 2 diabetes. In the study,
blood glucose was decreased significantly from 179 + 24 to
137 + 20.2 mg/dL as a result of consuming diet containing
fenugreek. Glucose tolerance improved in both groups and
signs of hyperphagia and polyuria were also improved. Other
performed case studies have shown that seed of Fenugreek
controls and improves blood sugar in persons with type 2
diabetes.55
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Treating Body Weakness and Anorexia. This plant is effective in
treatment of osteomyelitis and skeletal tuberculosis in children.
Some diseases resulted by anorexia and myasthenia can be
treated due to the presence of iron, phosphorous, carbohy-
drates, diastases, and other nitrogenous substances in this plant.
This plant can also be used for different cases where prescrip-
tion of iron and phosphorous supplements is necessary.25
Toxicology Studies. Changes related to weight, clinical signs, and
serum variables of toxicity like serum glutamic oxaloacetic
transaminase and serum glutamic pyruvic transaminase, alka-
line phosphatase, creatinine, bilirubin, and blood urea resulting
from consumption of fenugreek seed were studied in one study
performed on 60 type 2 diabetic patients for 24 weeks. At the
beginning of the study both control and treatment groups
received daily 300 g of carbohydrates for 7 days and after this
period their blood samples were taken to determine base size of
variables. A total of 25 g of powdered fenugreek seed was
added to the usual diet of patients with diabetes in the day 7.
Patients receiving fenugreek seed showed a nonsignificant
weight change of 1+ 1.6 kg. Some individuals who received
fenugreek leaf showed digestive problems like diarrhea and
cramp that were eliminated after 3 to 4 days. No considerable
change occurred in blood variables and no renal or liver side
effects were observed.56
Side Effects. No special side effects have been reported for fenu-
greek. One case of decrease in the awareness level of a 5-week
old infant who was given fenugreek-containing herbal tea was
reported. The problem was related to a metabolism disorder
and presence of sotolon in fenugreek seed used in herbal tea.57
Sotolon is a lactone derivative and a powerful aromatic
compound, with a typical smell of curry or fenugreek and is the
major aroma component of fenugreek seed. It is also present in
roast tobacco, aged sake and white wine, and dried fruiting
bodies of the mushroom.57 Sotolon can pass through the body
relatively unchanged, and consumption of foods high in soto-
lon, such as fenugreek, can impart a maple syrup aroma to
one’s sweat and urine. In some individuals with genetic disor-
der, it is spontaneously produced in their bodies and excreted in
their urine, leading to the characteristic smell caused by the
disease.57
Use in the Lactation Period. Fenugreek can enhance breast milk
production. However, with regard to studies performed,
breast-feeding women are recommended to consider the fol-
lowing when consuming fenugreek seeds58:
1. Fenugreek should be consumed carefully by women
who have signs of asthma or digestive disorders.
2. Minimum amount of consumption that provides effect
should be considered.
3. It should be avoided in women with blood pressure and
patients with cardiovascular diseases.
4. Women who have sensitive skin should check sensitiv-
ity to fenugreek.
5. Women who use warfarin plus aspirin should use fenu-
greek with caution.
6. Women who use fenugreek for their milk supply
increase should avoid long-term use of it. It is recom-
mended to check coagulation time and blood glucose
test during the consumption period.
Dose and method of use. Use 5 to 10 g thrice as powder per
day at mealtimes.58
Drug interaction. No considerable drug interaction has been
reported.
Discussion
Fenugreek has played an extensive role since ancient times in
treating and preventing diseases. The conducted studies also
have confirmed many of these traditional applications and have
shown clearly therapeutic value of this plant and abilities of the
traditional medicine. However, the scientific evidence to deter-
mine the mechanism of action of this plant is not enough. Fenu-
greek has a considerable antidiabetic effect. It can slow down
the absorption of sugar in the gastrointestinal tract and stimu-
late insulin release, resulting in lowering the blood sugar in
diabetic patients.59 Fenugreek is used for seveeral other con-
ditions such as inflammation, loss of appetite, upset stomach,
gastritis, atherosclerosis, and hypertension. Breast-feeding
women sometimes use fenugreek to promote milk flow. How-
ever, the mechanisms of action in these conditions have not
been established. Fenugreek has high level of iron and can be
used for iron-deficient patients.25
It is used for kidney complications and some other toxici-
ties. It has antioxidant activity and it seems that antioxidant
property of this plant is one of the main effective factors in cre-
ating effects of fenugreek.59 The antioxidant property of the
plant has been attributed to the presence of many active phyto-
chemicals, including flavonoids, plant sterols, vitamins, cumar-
ins, terpenoids, carotenoids, curcumins, lignin, and saponin.
However, the phenolic compounds have had the highest contri-
bution in this effect. So, there has been a significant correlation
between the polyphenolic components present in the extract
and its antioxidant activity.60
Free radicals have been shown to induce oxidative stress
and are implicated in a wide variety of diseases, including
diabetes,61,62 athrosclerosis,63,64 cardiovascular diseases,65,66
neurological disorders,67,68 and learning disabilities.69,70 These
conditions involve many changes, including alterations redox
state.71,72 Various experimental and clinical trials have shown
that plants that have antioxidant activity can combat pathologic
conditions especially for the treatment and prevention of
life-threatening diseases such as diabetes,73,74 cancer,75,76
infections,77,78 and gastrointestinal disorders.79,80 Medicinal
plants—because they contain antioxidant compounds, bioac-
tive compounds, phenols, flavonoids, and anthocyanin—have
been shown to counteract these conditions and are capable of
providing drug supply in complementary medicine.81-109 A lot
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of these plants have previously been used for preparation of
new drugs or have shown promising results.110-121 Therefore,
fenugreek, which possesses phenolic compounds and antioxi-
dant activity should have the ability to counteract these situa-
tions and might be a good candidate for a herbal drug.
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